Company Name: Gemphire Therapeutics Inc.   

Gemphire Therapeutics Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of therapies designed to treat dyslipidemia.

Ticker Symbol: GEMP (NASDAQ)

Company Website:  http://www.gemphire.com/

Social Media: Gemphire Therapeutics LinkedIn

Headquarters: Northville, Michigan